Ligand · KRY
KRY · 4-[3-(2,4-difluorophenyl)-2-oxo-2,3-dihydro-1H-imidazol-1-yl]benzene-1-sulfonamide
KRY, 4-[3-(2,4-difluorophenyl)-2-oxo-2,3-dihydro-1H-imidazol-1-yl]benzene-1-sulfonamide (C15 H11 F2 N3 O3 S, 351.3 g/mol), in the MolNFT structures on GenesisL1: bound in 3 records (2 PDB entries). Every binding site with its residues…
- Component
- KRY
- Formula
- C15 H11 F2 N3 O3 S
- Class
- ligand
- Structures
- 3
- PDB entries
- 2
Binding sites
KRY in 3 structures; the first of them:
- 6NLV · Selective inhibition of carbonic anhydrase IX activity, using compound SLC-149, displays… · KRY A302 · binds GLN92, HIS94, HIS96, GLU106, HIS119, VAL121, VAL131, GLY132 and 10 more
- 6NLV · Selective inhibition of carbonic anhydrase IX activity, using compound slc-149, displays… · KRY A302 · binds GLN92, HIS94, HIS96, HIS119, VAL121, VAL131, GLY132, VAL135 and 6 more
- 6NM0 · Selective inhibition of carbonic anhydrase IX activity, using compound slc-149, displays… · KRY A302 · binds HIS94, HIS96, GLU106, HIS119, VAL121, PHE131, GLY132, VAL143 and 6 more
Residues it binds most
VAL 3, HIS 3, THR 3, LEU 3, PRO 2, GLY 3, TRP 3, GLN 2, GLU 2, SER 2 (residue and the binding sites it lines).
Found with
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.